• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Fractyl Health, Inc. - Common Stock (NQ:GUTS)

    0.7056 -0.0011 (-0.16%)
    Streaming Delayed Price Updated: 12:35 PM EDT, Sep 3, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Fractyl Health, Inc. - Common Stock

    < Previous 1 2 3 4 5 6 Next >
    News headline image
    Did You Lose Money Investing in Fractyl Health, Inc.? Robbins LLP Urges Investors with Significant Losses to Contact the Firm for Information About Their Rights Against GUTS
    San Diego, California--(Newsfile Corp. - September 3, 2026) - Shareholder rights law firm Robbins LLP informs investors that a class... 
    Via Newsfile
    News headline image
    SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Fractyl Health, Inc. (GUTS)
    From Bernstein Liebhard LLP
    Via GlobeNewswire
    News headline image
    Pomerantz Law Firm Announces the Filing of a Class Action Against Fractyl Health, Inc. and Certain Officers – GUTS
    From Pomerantz LLP
    Via GlobeNewswire
    Fractyl Health Inc (NASDAQ:GUTS) Q1 Earnings: Net Income Swing Masks Core Operating Burn as Key Revita Data Readout Looms ↗
    Via Chartmill
    News headline image
    Fractyl Health Eyes 2028 Revita Launch for Post-GLP-1 Weight Maintenance ↗
    Fractyl Health (NASDAQ:GUTS) outlined a commercial strategy for its investigational Revita procedure, positioning the one-time endoscopic therapy as a potential option for patients seeking to maintain... 
    Via MarketBeat
    News headline image
    Deadline Approaching: Fractyl Health, Inc. (GUTS) Shareholders Who Lost Money Urged To Contact Law Offices of Howard G. Smith
    From Law Offices of Howard G. Smith
    Via Business Wire
    News headline image
    Deadline Alert: Fractyl Health, Inc. (GUTS) Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud Lawsuit
    From Glancy Prongay Wolke & Rotter LLP
    Via Business Wire
    News headline image
    Deadline Soon: Fractyl Health, Inc. (GUTS) Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz About Securities Fraud Lawsuit
    From The Law Offices of Frank R. Cruz
    Via Business Wire
    News headline image
    Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of October 20, 2026 in Fractyl Health, Inc. Lawsuit - GUTS
    From Levi & Korsinsky, LLP
    Via Business Wire
    News headline image
    Law Offices of Howard G. Smith Encourages Fractyl Health, Inc. (GUTS) Shareholders To Inquire About Securities Fraud Class Action
    From Law Offices of Howard G. Smith
    Via Business Wire
    News headline image
    Law Offices of Frank R. Cruz Encourages Fractyl Health, Inc. (GUTS) Shareholders to Inquire About Securities Fraud Class Action
    From Law Offices of Frank R. Cruz
    Via Business Wire
    News headline image
    Securities Fraud Investigation Into Fractyl Health, Inc. (GUTS) Announced – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm
    From Glancy Prongay Wolke & Rotter LLP
    Via Business Wire
    News headline image
    Faruqi & Faruqi, LLP Urges Fractyl Health, Inc. (NASDAQ: GUTS) Investors to Seek Counsel Before the October 20, 2026 Lead Plaintiff Deadline in the Securities Class Action
    From Faruqi & Faruqi, LLP
    Via Business Wire
    News headline image
    Fractyl Health, Inc. (GUTS) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
    From Law Offices of Howard G. Smith
    Via Business Wire
    News headline image
    Securities Fraud Investigation Into Fractyl Health, Inc. (GUTS) Announced – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz
    From The Law Offices of Frank R. Cruz
    Via Business Wire
    News headline image
    Stockholder Alert: Robbins LLP Informs Investors of the Fractyl Health, Inc. Class Action
    From Robbins LLP
    Via Business Wire
    News headline image
    Fractyl Health to Host Virtual Commercial Strategy Day on Tuesday, September 1, 2026: The Potential Path to Commercializing Revita®, a Procedural Therapy for Post-GLP-1 Weight Maintenance
    From Fractyl Health, Inc.
    Via GlobeNewswire
    News headline image
    Fractyl Health Eyes Q4 Revita Data, Launches Rejuva Gene Therapy Trial ↗
    Fractyl Health (NASDAQ:GUTS) is advancing two one-time treatment approaches intended to provide durable benefits for obesity, type 2 diabetes and related metabolic diseases, Chief Executive Officer... 
    Via MarketBeat
    News headline image
    Fractyl Health Q2 Earnings Call Highlights ↗
    Fractyl Health (NASDAQ:GUTS) said its Revita endoscopic procedure showed durable weight-maintenance results one year after patients discontinued GLP-1 therapy, while the company reaffirmed plans to... 
    Via MarketBeat
    Topics Earnings
    News headline image
    Fractyl Health Reports Second Quarter 2026 Financial Results and Business Updates
    From Fractyl Health, Inc.
    Via GlobeNewswire
    News headline image
    Fractyl Health to Report Second Quarter 2026 Financial Results and Provide Business Updates on August 10, 2026
    From Fractyl Health, Inc.
    Via GlobeNewswire
    News headline image
    Fractyl Health to Participate in Upcoming Investor Events
    From Fractyl Health, Inc.
    Via GlobeNewswire
    These stocks are moving in today's session ↗
    Via Chartmill
    News headline image
    Fractyl Health Says Revita Helped Patients Keep Weight Off After Stopping GLP-1s ↗
    Fractyl Health (NASDAQ:GUTS) reported one-year data from the randomized midpoint cohort of its REMAIN-1 study, saying its Revita procedure helped patients maintain a larger share of GLP-1-induced... 
    Via MarketBeat
    News headline image
    Fractyl Health Reports Positive Randomized Data from REMAIN-1 Midpoint Cohort Demonstrating Durable Weight Maintenance One Year After GLP-1 Discontinuation
    From Fractyl Health, Inc.
    Via GlobeNewswire
    News headline image
    Fractyl Health Reports Positive One-Year REVEAL-1 Open-Label Results Showing Sustained Post-GLP-1 Weight Maintenance After a Single Revita® Procedure
    From Fractyl Health, Inc.
    Via GlobeNewswire
    News headline image
    Fractyl Health Appoints Mike Zumdahl as Senior Vice President, Market Access and Commercial Strategy
    Experienced market access leader joins to build reimbursement and health economic infrastructure for Revita® ahead of anticipated REMAIN-1 Pivotal Cohort topline data in early Q4 2026 
    From Fractyl Health, Inc.
    Via GlobeNewswire
    News headline image
    Fractyl Health Q1 Earnings Call Highlights ↗
    Fractyl Health (NASDAQ:GUTS) said it remains on track to report pivotal data for its Revita therapy in early fourth quarter 2026, as management highlighted clinical, regulatory and reimbursement... 
    Via MarketBeat
    Topics Earnings
    News headline image
    Fractyl Health Reports First Quarter 2026 Financial Results and Business Updates
    From Fractyl Health, Inc.
    Via GlobeNewswire
    News headline image
    Fractyl Health Authorized to Initiate First-in-Human Trial of RJVA-001 in the Netherlands: First Gene Therapy Candidate to Enter Clinical Development for Type 2 Diabetes
    From Fractyl Health, Inc.
    Via GlobeNewswire
    < Previous 1 2 3 4 5 6 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.